This news article was originally written in Spanish. It has been automatically translated for your convenience. Reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace a human translator. The original article in Spanish can be viewed at Lanxess Fine Chemicals abre una planta en Estados Unidos
LANXESS Fine Chemicals opens in United States
15/01/2008
January 21, 2008
Lanxess chemical specialties group has opened a new plant for the pharmaceutical business of its subsidiary Saltigo in Redmond (Washington), in United States. These new laboratories will provide a base Saltigo for produce and research in the pharmaceutical market in the world. Saltigo will make use of these facilities previously used by Icos Corporation, a subsidiary of the American pharmaceutical group Eli Lilly & Co. For the moment, they will begin to work in these facilities up to 25 people, which will produce pharmaceutical ingredients for early clinical trials including clinical Phase IIa.
Saltigo operates globally as a specialist in the field of the exclusive synthesis (Custom Synthesis) with about 1,400 employees. This subsidiary, belonging to 100 per cent to the Lanxess group, provides services to three lines of business - pharmaceutical, agrochemical and specialty chemicals. The company offers a full range of services for clients, such as research in alternative routes, improvements in process, analytical methods, handling, production and support regulatory. Saltigo obtains 90 percent of its sales, which reached the 400 million euros in 2006, in the field of Custom Synthesis.
